WHO Adds Two Cancer Drugs to Essential Medicines List
The World Health Organisation says the two recently developed immunotherapies - anivolumab and pembrolizumab - have delivered up to 50% survival rates for advanced melanoma, a cancer that until recently was incurable. WHO's Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritise critical health products that should be widely available and affordable throughout health systems.
AllAfrica publishes around 700 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
AllAfrica is a voice of, by and about Africa - aggregating, producing and distributing 700 news and information items daily from over 140 African news organizations and our own reporters to an African and global public. We operate from Cape Town, Dakar, Abuja, Monrovia, Nairobi and Washington DC.